pharma · Asthma · Pharmacokinetics · AMPH
Amphastar France Pharmaceuticals
Amphastar France Pharmaceuticals trial registry — 21 ClinicalTrials.gov studies with program phase, status, and indication context.
USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga HQ
1996 Founded
46 Employees
Public company Type
AMPH · NYSE Ticker
Company details
- Status
- Public
- HQ
- USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga
- Founded
- 1996
- Employees
- 46
- Programs
- 18
- Drugs
- 15
- Patents
- 15
Amphastar France Pharmaceuticals clinical trials
Registry index of 21 ClinicalTrials.gov studies linked to Amphastar France Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Amphastar France Pharmaceuticals trial registry — 21 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Amphastar France Pharmaceuticals.
-
API-E004-CL-A — Phase 2
Clinical update -
API-E004-CL-B4 — Phase 2
Clinical update -
Epinephrine Inhalation Aerosol, HFA — Phase 2
Clinical update -
epinephrine inhalation aerosol — Phase 3
Clinical update -
Epinephrine (0.125 mg/inhalation) — Approved
Clinical update -
E004 (Epinephrine Inhalation Aerosol) HFA-MDI — Phase 3
Clinical update -
Armstrong Albuterol Sulfate Inhalation Aerosol — Phase 3
Clinical update -
Arm T1: Primatene Mist HFA — Phase 2
Clinical update